These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8698447)

  • 1. Ambulatory monitoring uncorrected for placebo overestimates long-term antihypertensive action. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators.
    Staessen JA; Thijs L; Bieniaszewski L; O'Brien ET; Palatini P; Davidson C; Dobovisek J; Jääskivi M; Laks T; Lehtonen A; Vanhanen H; Webster J; Fagard R
    Hypertension; 1996 Mar; 27(3 Pt 1):414-20. PubMed ID: 8698447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
    JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
    Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators.
    Gasowski J; Staessen JA; Celis H; Fagard RH; Thijs L; Birkenhäger WH; Bulpitt CJ; Fletcher AE; Arabidze GG; de Leeuw P; Dollery CT; Duggan J; Kawecka-Jaszcz K; Leonetti G; Nachev C; Safar M; Rodico JL; Rosenfeld J; Seux ML; Tuomilehto J; Webster J; Yodfat Y
    J Hum Hypertens; 1999 Feb; 13(2):135-45. PubMed ID: 10100063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
    Forette F; Seux ML; Staessen JA; Thijs L; Babarskiene MR; Babeanu S; Bossini A; Fagard R; Gil-Extremera B; Laks T; Kobalava Z; Sarti C; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Birkenhäger WH;
    Arch Intern Med; 2002 Oct; 162(18):2046-52. PubMed ID: 12374512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy in older patients with isolated systolic hypertension: the Syst-Eur experience in general practice. The Syst-Eur Investigators.
    Celis H; Yodfat Y; Thijs L; Clement D; Cozic J; De Cort P; Forette F; Grégoire M; Heyrman J; Stibbe G; Van den Haute M; Staessen J; Fagard R
    Fam Pract; 1996 Apr; 13(2):138-43. PubMed ID: 8732324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
    Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J; Boileau G
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1154-9. PubMed ID: 8998248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy in old patients with isolated systolic hypertension: fourth progress report on the Syst-Eur trial.
    Antikainen R; Tuomilehto J; Thijs L; Vanhanen H; Sarti C; Birkenhäger W; Arabidze G; Fagard R; Grigorow M; Jankulova K; Jääskivi M; Kohonen-Jalonen P; Laks T; Lazebnic L; Mantova S; Nachev C; Kermova P; Vänskä O; Yodfat Y; Bulpitt CJ; Staessen JA
    J Hum Hypertens; 1997 May; 11(5):263-9. PubMed ID: 9205931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the trough-to-peak ratio in parallel-group trials. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators.
    Staessen JA; Thijs L; Bijttebier G; Clement D; O'Brien ET; Palatini P; Rodicio JL; Rosenfeld J; Fagard R
    Hypertension; 1997 Feb; 29(2):659-67. PubMed ID: 9040453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.
    Staessen JA; Fagard R; Thijs L; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Babarskiene MR; Forette F; Kocemba J; Laks T; Leonetti G; Nachev C; Petrie JC; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Zanchetti A
    Arch Intern Med; 1998 Aug 10-24; 158(15):1681-91. PubMed ID: 9701103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Voyaki SM; Staessen JA; Thijs L; Wang JG; Efstratopoulos AD; Birkenhäger WH; de Leeuw PW; Leonetti G; Nachev C; Rodicio JL; Tuomilehto J; Fagard R;
    J Hypertens; 2001 Mar; 19(3):511-9. PubMed ID: 11288822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
    Silagy CA; McNeil JJ; McGrath BP
    Am J Cardiol; 1992 Nov; 70(15):1299-305. PubMed ID: 1442581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syst-Eur--a multicenter trial on the treatment of isolated systolic hypertension in the elderly: first interim report.
    Staessen J; Amery A; Birkenhäger W; Bulpitt CJ; Cox J; de Leeuw P; De Cort P; Fagard R; Fletcher A; Forette F
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):120-5. PubMed ID: 1375678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.
    Fagard R; Lijnen P; Pardaens K; Thijs L; Vinck W
    J Hum Hypertens; 2001 Mar; 15(3):161-7. PubMed ID: 11317199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group.
    Zanchetti A; Omboni S
    Am J Hypertens; 2001 Feb; 14(2):129-34. PubMed ID: 11243303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group.
    Wang JG; Staessen JA; Gong L; Liu L
    Arch Intern Med; 2000 Jan; 160(2):211-20. PubMed ID: 10647760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrendipine in older patients with isolated systolic hypertension: second progress report on the SYST-EUR trial.
    Staessen J; Bert P; Bulpitt C; De Cort P; Fagard R; Fletcher A; Kivinen P; Lehtomaki E; Leonetti G; O'Brien E
    J Hum Hypertens; 1993 Jun; 7(3):265-71. PubMed ID: 8345494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.